Related Experiment Video
Updated: Feb 8, 2026

High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers
Published on: March 24, 2023
Drug transporters and anthracycline-induced cardiotoxicity
Kevin M Huang1, Shuiying Hu1, Alex Sparreboom1
1Division of Pharmaceutics & Pharmaceutical Chemistry, College of Pharmacy & Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.
Abstract:
The solute carrier superfamily comprises of uptake transporters that can contribute to the absorption and elimination of a broad array of clinically important drugs. Recent studies have suggested that the tissue-specific expression of these transporters may have important consequences for an individual's susceptibility to drug-induced organ damage or to drug-drug interactions. Polymorphic variants have been identified in genes encoded by this family, and some of these have been associated with functional changes in transport function and response to anthracycline-induced toxicity and efficacy. Here, we review recent advances in the role solute carrier transporters play in anthracycline-induced cardiotoxicity, highlight potential implications of genetic variants that may contribute to drug response and discuss novel technologies to study mechanisms of anthracycline transport.
Insights
Solute carrier transporters affect drug absorption and elimination. Genetic variations in these transporters influence susceptibility to drug toxicity and interactions, impacting treatment outcomes.
Area of Science:
- Pharmacology
- Genetics
- Biochemistry
Background:
- Solute carrier (SLC) transporters are crucial for drug absorption and elimination.
- Tissue-specific SLC expression impacts drug response and toxicity.
- Genetic variants in SLCs can alter drug transport and efficacy.
Purpose of the Study:
- To review the role of SLC transporters in anthracycline-induced cardiotoxicity.
- To highlight the implications of genetic variants on drug response.
- To discuss novel technologies for studying anthracycline transport.
Main Methods:
- Literature review of recent advances in SLC transporter research.
- Analysis of studies on genetic variants and their functional impact.
- Discussion of emerging technologies for transport mechanism investigation.
Main Results:
- SLC transporters play a significant role in anthracycline cardiotoxicity.
- Genetic variations in SLCs are associated with altered anthracycline efficacy and toxicity.
- Novel technologies offer new insights into SLC-mediated drug transport.
Conclusions:
- Understanding SLC transporter function and genetics is vital for personalized medicine.
- Targeting SLCs may offer strategies to mitigate drug-induced toxicity.
- Further research using advanced technologies will elucidate SLC-mediated drug effects.
More Related Videos
Related Concept Videos
Cellular Membranes and Drug Transport
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Hepatic Drug Clearance: Role of Transporters
Drug Absorption Mechanism: Passive Membrane Transport
Facilitated Transport
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...

